Maghsoodi M
Drug Applied Research Center and School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
AAPS PharmSciTech. 2009;10(1):120-8. doi: 10.1208/s12249-009-9186-5. Epub 2009 Jan 31.
Microparticles of naproxen with Eudragit L100 and Aerosil were prepared by the emulsion solvent diffusion method in order to avoid local gastrointestinal irritation, one of the major side effects of nonsteroidal anti-inflammatory drugs after oral ingestion. The process of preparation involved the use of ethanol as good solvent, dichloromethane as a bridging liquid, water as poor solvent, Aerosil as anti-adhesion agent, and sodium dodecyl sulfate to aid in the dispersion of the drug and excipients into the poor solvent. The obtained microparticles were evaluated for micromeritic properties, yield, encapsulation efficiency, drug physical state, and drug release properties. The influence of formulation factors and preparation condition (polymer/naproxen ratio, Aerosil/polymer ratio, and the initial difference of temperature between the solvent and nonsolvent) on the properties of the microparticles were also examined. The resultant microparticles were finely spherical and uniform with high incorporation efficiency (>79%) and yield (>71%). The incorporation efficiency was enhanced with increasing the ratio of excipients to drug and the initial difference of temperature between the solvent and nonsolvent. The mean diameter of the microparticles was influenced by all of the manufacturing parameters. Studies carried out to characterize the micromeritic properties of formulations, such as flowability and packability, showed that microparticles were suitable for further pharmaceutical manipulation (e.g., capsule filling). Drug release studies of the microparticles confirmed the gastroresistance, and mathematical studies showed that the drug released followed a Hixon and Crowell kinetic. These microparticles represent a simple method for the preparation of drug-loaded enteric microparticles with desired micromeritic properties and gastroresistance release.
为避免局部胃肠道刺激(这是非甾体抗炎药口服后主要的副作用之一),采用乳液溶剂扩散法制备了含欧巴代L100和气相二氧化硅的萘普生微粒。制备过程中使用乙醇作为良溶剂,二氯甲烷作为 bridging 液,水作为不良溶剂,气相二氧化硅作为抗黏附剂,以及十二烷基硫酸钠来辅助药物和辅料分散到不良溶剂中。对所得微粒的粉体学性质、收率、包封率、药物物理状态和药物释放性质进行了评估。还考察了制剂因素和制备条件(聚合物/萘普生比例、气相二氧化硅/聚合物比例以及溶剂和非溶剂之间的初始温度差)对微粒性质的影响。所得微粒呈精细球形且均匀,具有高包封率(>79%)和收率(>71%)。随着辅料与药物比例以及溶剂和非溶剂之间初始温度差的增加,包封率提高。微粒的平均直径受所有制造参数的影响。对制剂粉体学性质(如流动性和可压性)进行表征的研究表明,微粒适合进一步的药物加工操作(如胶囊填充)。微粒的药物释放研究证实了其抗胃酸作用,数学研究表明药物释放遵循希克森和克罗威尔动力学。这些微粒代表了一种制备具有所需粉体学性质和抗胃酸释放的载药肠溶微粒的简单方法。